Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Nov 9, 2017
Clinical News

J&J's Stelara headed for Phase III in lupus

BioCentury | Oct 3, 2016
Clinical News

Stelara ustekinumab regulatory update

BioCentury | May 30, 2016
Clinical News

Stelara ustekinumab: Phase III data

BioCentury | Mar 28, 2016
Clinical News

Stelara ustekinumab: Phase III data

BioCentury | Dec 7, 2015
Clinical News

Stelara ustekinumab regulatory update

BioCentury | Oct 26, 2015
Clinical News

Stelara ustekinumab: Phase III data

BioCentury | Sep 21, 2015
Clinical News

Stelara ustekinumab regulatory update

BioCentury | Jun 1, 2015
Clinical News

Stelara ustekinumab regulatory update

BioCentury | Mar 23, 2015
Clinical News

Stelara ustekinumab regulatory update

BioCentury | Jan 19, 2015
Clinical News

Stelara ustekinumab regulatory update

Items per page:
1 - 10 of 68